|Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV||
||NIH / Industry||
||30||All||18 Years to 99 Years (Adult, Older Adult)||NCT02124044||140065
|February 2014||March 2016||November 2016||April 28, 2014||May 16, 2017||April 13, 2017||
|2||NCT00854802||Completed||A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients||
||290||All||18 Years to 65 Years (Adult, Older Adult)||NCT00854802||Debio 025-HCV-205
|January 2009||September 2010||September 2010||March 3, 2009||February 17, 2016||
† Study has passed its completion date and status has not been verified in more than two years.